Itau Unibanco Holding S.A. Aerie Pharmaceuticals Inc Transaction History

Itau Unibanco Holding S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$17.72 - $25.1 $11,092 - $15,712	-626 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$28.97 - $48.21 $16,310 - $27,142	-563 Reduced 47.35%	626 $18,000
Q4 2018 Feb 13, 2019	BUY	$33.0 - $60.04 $3,597 - $6,544	109 Added 10.09%	1,189 $42,000
Q3 2018 Nov 13, 2018	SELL	$56.15 - $73.9 $1,684 - $2,217	-30 Reduced 2.7%	1,080 $66,000
Q2 2018 Aug 13, 2018	SELL	$47.85 - $70.45 $9,952 - $14,653	-208 Reduced 15.78%	1,110 $75,000
Q1 2018 May 14, 2018	BUY	$51.15 - $61.0 $45,983 - $54,839	899 Added 214.56%	1,318 $72,000
Q4 2017 Feb 09, 2018	BUY	$50.85 - $65.1 $1,576 - $2,018	31 Added 7.99%	419 $25,000
Q3 2017 Nov 14, 2017	BUY	$48.6 - $60.1 $18,856 - $23,318	388	388 $60,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.